Neurol. praxi. 2015;16(3):159-162

Cerebral amyloid angiopathy

MUDr. Pavel ©iarnik, MUDr. Zuzana Čarnická, MUDr. Lucia Kríľová, MUDr. Stanislav ©utovský, PhD., MUDr. Veronika Vestenická, PhD., doc. MUDr. Branislav Kollár, PhD.
I. neurologická klinika LF UK a UNB, Bratislava

Cerebral amyloid angiopathy is characterized by amyloid deposition in the walls of cortical and leptomeningeal arteries and arterioles. Disorder occurs most frequently as a sporadic form in the elderly. Incidence of sporadic form increases with advancing age. Hereditary forms are earlier in onset. The most important clinical consequence of the disease are recurrent lobar intracerebral hemorrhages. Progressive cognitive impairment and dementia can also be present. In a case report of 76-year-old patient with recurrent intracerebral hemorrhage and dementia authors present current options of diagnostics, prevention and treatment of cerebral amyloid angiopathy.

Keywords: cerebral amyloid angiopathy, recurrent intracerebral hemorrhages, cognitive impairment

Published: June 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©iarnik P, Čarnická Z, Kríľová L, ©utovský S, Vestenická V, Kollár B. Cerebral amyloid angiopathy. Neurol. praxi. 2015;16(3):159-162.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arima H, Chalmers J. PROGRESS: prevention of recurrent stroke. J Clin Hypertens. 2011; 13: 693-702. Go to original source... Go to PubMed...
    2. Athyros VG, Tziomalos K, Karagiannis A, Wierzbicki AS, Mikhailidis DP. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? Curr Opin Cardiol. 2010; 25: 406-410. Go to original source... Go to PubMed...
    3. Attems J, Lauda F. Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy. J Neurol. 2008; 255: 70-76. Go to original source... Go to PubMed...
    4. Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011; 7: 1-9. Go to original source... Go to PubMed...
    5. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem MA, Breteler M. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009; 8: 165-174. Go to original source... Go to PubMed...
    6. Haacke E, Delproposto Z, Chaturvedi S, Sehgal V, Tenzer M, Neelavalli J, Kido D. Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. Am J Neuroradiol. 2007; 28: 316-317.
    7. Chao CP, Kotsenas AL, Broderick DF. Cerebral Amyloid Angiopathy: CT and MR Imaging Findings. Radiographics. 2006; 26: 1517-1531. Go to original source... Go to PubMed...
    8. Jellinger K. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm. 2002; 109: 813-836. Go to original source... Go to PubMed...
    9. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001; 56: 537-539. Go to original source... Go to PubMed...
    10. Linn J, Halpin A, Demaerel P, Ruhland J, Giese A, Dichgans M, Van Buchem M, Bruckmann H, Greenberg S. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010; 74: 1346-1350. Go to original source... Go to PubMed...
    11. Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA. Stroke: Pathophysiology, diagnosis, and management. New York: Churchill Livingstone; 2004: 1616.
    12. Morgenstern LB, Hemphill JC, Anderson C, Becker K, Broderick JP, Connolly ES, Greenberg SM, Huang JN, Macdonald RL, Messé SR. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2010; 41: 2108-2129. Go to original source... Go to PubMed...
    13. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9: 689-701. Go to original source... Go to PubMed...
    14. Rannikmäe K, Samarasekera N, Martînez-Gonzâlez NA, Salman RS, Sudlow CL. Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2013; 84: 901-908. Go to original source... Go to PubMed...
    15. Smith EE, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Curr Atheroscler Rep. 2003; 5: 260-266. Go to original source... Go to PubMed...
    16. Sudlow C, González NA, Kim J, Clark C. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls. Stroke. 2006; 37: 364-370. Go to original source... Go to PubMed...
    17. Weller RO, Boche D, Nicoll JA. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta neuropathol. 2009; 118: 87-102. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.